APA (7th ed.) Citation

Y, H., R, C., Z, Y., F, W., K, L., J, L., & Y, Z. (2022). Population Pharmacokinetic Modeling of Lenvatinib in Chinese Patients With Advanced Hepatocellular Carcinoma Using Real-World Data. Journal of clinical pharmacology, 62(12), 1507. https://doi.org/10.1002/jcph.2103

Chicago Style (17th ed.) Citation

Y, Hu, Chen R, Ye Z, Wei F, Lin K, Liu J, and Zeng Y. "Population Pharmacokinetic Modeling of Lenvatinib in Chinese Patients With Advanced Hepatocellular Carcinoma Using Real-World Data." Journal of Clinical Pharmacology 62, no. 12 (2022): 1507. https://doi.org/10.1002/jcph.2103.

MLA (9th ed.) Citation

Y, Hu, et al. "Population Pharmacokinetic Modeling of Lenvatinib in Chinese Patients With Advanced Hepatocellular Carcinoma Using Real-World Data." Journal of Clinical Pharmacology, vol. 62, no. 12, 2022, p. 1507, https://doi.org/10.1002/jcph.2103.